Ozanimod-treated patients exhibited improvements in cognitive processing speed in the phase 3 SUNBEAM trial of relapsing multiple sclerosis (RMS)J. Deluca, D. Huang,J. A. Cohen,B. A. C. Cree,Y. Chen,D. Campagnolo,J. K. Sheffield, G. Comi,L. KapposMULTIPLE SCLEROSIS JOURNAL（2018）引用 1|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
